Pentobarbital sodium

Pentobarbital sodium is a short-acting barbiturate that depresses the central nervous system by enhancing the inhibitory action of GABA. It has been used as a sedative-hypnotic, anticonvulsant, and anesthetic, with current use largely limited to veterinary medicine. Due to its narrow therapeutic index, it carries significant risks including respiratory depression, dependence, and potential for misuse, and is therefore strictly regulated. It is grouped under the following drug class(es): Barbiturates, Controlled drug substances, Hypnotics and Sedatives. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Napental, Vetbutal, Auropan and Embutal. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 23676152.

CAS No 57-33-0
Molecular Formula C11H17N2NaO3
Molecular Weight 248.25 g/mol
Synonyms sodium;5-ethyl-4,6-dioxo-5-pentan-2-yl-1H-pyrimidin-2-olate

Frequently Asked Questions